Natural Products in Diabetes Mellitus 2.0

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".

Deadline for manuscript submissions: 28 June 2024 | Viewed by 1405

Special Issue Editor


E-Mail Website
Guest Editor
División de Estudios de Posgrado, C.A. Bioingeniería Básicay Aplicada, Facultad de Ingeniería, Universidad Autónoma de Querétaro, C. U. Cerro de las Campanas, S/N, Querétaro 76010, Mexico
Interests: nutraceuticals; secondary metabolite; prebiotics; value added
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Diabetes mellitus (DM) is a chronic disease characterized by a state of hyperglycemia. This sustained increase in glucose levels induces oxidative damage, which can contribute in different ways to the development of chronic complications. Such complications have been directly or indirectly related to the high morbidity and mortality of DM. The increase in the prevalence of this disease is more marked in developing countries, although it does not exclude developed countries. Additionally, this disease represents a high cost to the health sector and to the patient. The prevention and control of DM consists of physical activity and diet modification. However, various natural products are used worldwide to aid in the control and prevention of DM.

Natural products come from various sources, such as plants, foods and microorganisms. They possess or generate bioactive compounds that may have antidiabetic activity, for which the mechanisms of action are diverse and range from the inhibition of enzymes such as alpha-amylase and alpha-glucosidase to the modification of hormonal activities involved in glucose homeostasis. Additionally, natural products can present diverse biological activities that can contribute to or generate synergy in the control and prevention of the predominant complications in DM, by reducing oxidative stress resulting from the increase in free radicals due to the high content of glucose in the blood. Therefore, natural products can contribute to antioxidant enzymatic activity.

However, the use of these natural products is generally part of traditional medicine, so there is not always information to support their use, dosage, toxicity, etc.

The study of the mechanisms of action of various natural products, either in isolation as an active substance or in a more complex form as an extract or in its natural state, is of interest since it provides knowledge for the development of therapeutic agents and adjuvant therapies for DM, in addition to generating information on dosage, toxicity, mechanisms of action, synergistic and/or antagonistic activity, etc.

For this Special Issue, we invite the submission of original contributions, reviews or short communications that contribute to the knowledge of natural products and their antidiabetic action, including either in vivo or in vitro models, therapeutic models, the characterization of compounds and extracts, and mechanisms of action.

Dr. Ana Angelica Feregrino-Perez
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • hypoglycemia
  • phenolic compounds
  • diabetes mellitus
  • therapeutic
  • ROS

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

27 pages, 2397 KiB  
Review
Updated Progress on Polysaccharides with Anti-Diabetic Effects through the Regulation of Gut Microbiota: Sources, Mechanisms, and Structure–Activity Relationships
by Xiaoyu Zhang, Jia Wang, Tingting Zhang, Shuqin Li, Junyu Liu, Mingyue Li, Jingyang Lu, Min Zhang and Haixia Chen
Pharmaceuticals 2024, 17(4), 456; https://doi.org/10.3390/ph17040456 - 2 Apr 2024
Viewed by 1198
Abstract
Diabetes mellitus (DM) is a common chronic metabolic disease worldwide. The disturbance of the gut microbiota has a complex influence on the development of DM. Polysaccharides are one type of the most important natural components with anti-diabetic effects. Gut microbiota can participate in [...] Read more.
Diabetes mellitus (DM) is a common chronic metabolic disease worldwide. The disturbance of the gut microbiota has a complex influence on the development of DM. Polysaccharides are one type of the most important natural components with anti-diabetic effects. Gut microbiota can participate in the fermentation of polysaccharides, and through this, polysaccharides regulate the gut microbiota and improve DM. This review begins by a summary of the sources, anti-diabetic effects and the gut microbiota regulation functions of natural polysaccharides. Then, the mechanisms of polysaccharides in regulating the gut microbiota to exert anti-diabetic effects and the structure–activity relationship are summarized. It is found that polysaccharides from plants, fungi, and marine organisms show great hypoglycemic activities and the gut microbiota regulation functions. The mechanisms mainly include repairing the gut burrier, reshaping gut microbiota composition, changing the metabolites, regulating anti-inflammatory activity and immune function, and regulating the signal pathways. Structural characteristics of polysaccharides, such as monosaccharide composition, molecular weight, and type of glycosidic linkage, show great influence on the anti-diabetic activity of polysaccharides. This review provides a reference for the exploration and development of the anti-diabetic effects of polysaccharides. Full article
(This article belongs to the Special Issue Natural Products in Diabetes Mellitus 2.0)
Show Figures

Figure 1

Back to TopTop